Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Warning Letters Dropped 24% In 2006; FDA Staffers Cite Funding, Turnover

This article was originally published in The Gray Sheet

Executive Summary

The number of medical device warning letters that cite quality system violations dropped for the second year in a row in 2006, leading two FDA officials to speculate that the downturn is a result of dwindling agency resources and a high investigator turnover rate

You may also be interested in...

Warning Letters Rebound After Slump; Are Seizures On The Rise?

FDA issued 108 device quality system warning letters in 2004, bringing the number back up to historic norms following unusually low levels in 2002 and 2003

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts